Quality measures for colonoscopy: a critical evaluation.
Clin Gastroenterol Hepatol
; 12(12): 1973-80, 2014 Dec.
Article
em En
| MEDLINE
| ID: mdl-24095973
ABSTRACT
In a recent article in The New York Times, "The $2.7 Trillion Medical Bill,"(1) colonoscopy was singled out for its cost. In their response, the leading gastroenterology professional societies highlighted colonoscopy's effectiveness and cost-effectiveness for the prevention of colorectal cancer (CRC). Affirming colonoscopy's central role in CRC prevention, both as a frontline test and as the final common pathway for other CRC screening modalities, requires strategies to measure and improve colonoscopy quality, particularly by controlling operator-dependent factors. Although colonoscopy is a powerful CRC screening test,(2-6) several recent studies have highlighted decreased protection, mainly against right-sided CRC,(5,7-16) an observation that has been linked to performance quality.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Colorretais
/
Colonoscopia
/
Pesquisa sobre Serviços de Saúde
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article